FDA Adverse Event Injury Summary report: N

DEPUY ASR XL FEM IMP SIZE 55

MDR report key: 2232828 · Received August 18, 2011

Report

Report Number
1818910-2011-15696
Event Type
Injury
Date Received
August 18, 2011
Date of Event
May 6, 2011
Report Date
May 23, 2014
Manufacturer
DEPUY INTERNATIONAL LTD. 8010379
Product Code
KWA
PMA / PMN Number
NA
Removal / Correction Number
Z-1749/1816-2011
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
UK
Reporter Occupation
UNKNOWN

Narratives

Additional Manufacturer Narrative · 1

THE ASR PLATFORM WAS VOLUNTARILY RECALLED FROM THE MARKET IN AUGUST 2010, AND THE ASR PRODUCT CODES ARE NOW CONSIDERED INACTIVE. FURTHER INVESTIGATION OF THIS INDIVIDUAL INCIDENT WILL NOT BE UNDERTAKEN, AS THERE IS AN ONGOING INVESTIGATION REGARDING THE ROOT CAUSE(S) AND/OR CORRECTIVE ACTIONS. (B)(4).

Additional Manufacturer Narrative · 1

THIS COMPLAINT IS STILL UNDER INVESTIGATION. DEPUY WILL NOTIFY THE FDA OF THE RESULTS OF THIS INVESTIGATION ONCE IT HAS BEEN COMPLETED. THE CORRECTION/REMOVAL REPORTING NUMBER LISTED APPLIES TO THE CORRESPONDING PRODUCT CODE SOLD DOMESTICALLY.

Additional Manufacturer Narrative · 1

IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL MEDWATCH, A FOLLOW-UP MEDWATCH WILL BE FILED AS APPROPRIATE. DEPUY STILL CONSIDERS THIS CASE CLOSED TO CAPA.

Description of Event or Problem · 1

THE PT WAS REVISED TO ADDRESS ALVAL.

Description of Event or Problem · 1

NEW ETQ RECORD CREATED IN ORDER TO UPDATE ETQ (LEGACY SYSTEM) COMPLAINT NUMBER (B)(4). REASON FOR ORIGINAL COMPLAINT - ASR REVISION - BI-LATERAL, ONLY ONE HIP IS DEPUY, OTHER HIP UNKNOWN, ALVAL / SOFT TISSUE REACTION. UPDATE: ADDITIONAL PRODUCTS RECEIVED FROM (B)(6), (B)(6) 2012. UPDATE - ADDED CORRECT HIP SIDE, AND ADDITIONAL REASON FOR REVISION AND DETAILS ABOUT THE STEM. TAKEN FROM EMAIL DATED (B)(6) 2014. RIGHT. REASON FOR REVISION : ELEVATED IONS, ARMD.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 DEPUY ASR XL FEM IMP SIZE 55 87KWA KWA DEPUY INTERNATIONAL LTD. 8010379 NA 2383980

Patients

Seq Age Sex Outcome Treatment
1 NA Required Intervention